Lantheus Alpha Therapy, LLC sold $777K of Perspective Therapeutics (CATX)

Executed Sep 3, disclosed Sep 8, 5 days later.

Value, as filed

$777K

247,932 sh across 2 lots

Executed

Sep 3

the trade date, as filed

Disclosed

Sep 8

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

LL Lantheus Alpha Therapy, LLC 10% owner profile →

Lantheus Alpha Therapy, LLC (10% owner) filed 3 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in Perspective Therapeutics, Inc. (CATX). The largest single filing was $777K of CATX (247,932 sh across 2 lots, as filed), executed Sep 3.

The name

CATX

Perspective Therapeutics, Inc. CATX · Healthcare · 5 filings in 24 months ticker →

Healthcare · Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Lantheus Alpha Therapy, LLC in CATX

CATXSALE Perspective Therapeutics, Inc. $131K
42,129 sh × $3.11
Exec Sep 2
Filed Sep 4 · 5:00 PM ET CATXSALE Perspective Therapeutics, Inc. $357K
113,914 sh across 2 lots
Exec Aug 31
Filed Sep 4 · 4:58 PM ET †